C
West Pharmaceutical Services, Inc. WST
$249.64 $0.710.29% NYSE
Recommendation
Dividend Power Score
Prev Close
$248.93
Volume
326,968
Avg Vol (90D)
802,221
Market Cap
$17.91B
Dividend & Yield
$1.07(0.43%)
52-Week Range
$187.43 - $325.20
P/E (TTM)
36.86
EPS (TTM)
$6.75
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
Countdown to West Pharmaceutical (WST) Q4 Earnings: A Look at Estimates Beyond Revenue and EPS
2/10/2026 - Zacks Investment Research
WST Q4 Earnings Preview: Can HVP Momentum Continue to Drive Margins?
2/9/2026 - Zacks Investment Research
Is It Time To Revisit West Pharmaceutical Services (WST) After Recent Share Price Rebound?
2/8/2026 - Simply Wall St
Envestnet Asset Management Inc. Cuts Position in West Pharmaceutical Services, Inc. $WST
2/8/2026 - MarketBeat
West Pharmaceutical Services, Inc. (WST): A Bull Case Theory
2/7/2026 - Insider Monkey
West Pharmaceutical Services, Inc. (WST): A Bull Case Theory
2/7/2026 - Yahoo! Finance: News
West Pharmaceutical Services (WST, $248.95) Moving Average Convergence Divergence (MACD) Histogram turned positive on February 6, 2026
2/7/2026 - Tickeron - Stocks
West Pharmaceutical Services Unveils Synchrony S1 Syringe System to Speed Drug Packaging Development
2/7/2026 - MarketBeat
West Pharmaceutical Services, Inc. (WST) Discusses Integrated Prefillable Syringe Systems to Streamline Drug Development and Reduce Complexity Transcript
2/5/2026 - SeekingAlpha
West Pharmaceutical Services, Inc. (WST) Discusses Integrated Prefillable Syringe Systems to Streamline Drug Development and Reduce Complexity Transcript
2/5/2026 - Seeking Alpha: Transcripts
West Pharmaceutical Services (WST) Earnings Expected to Grow: Should You Buy?
2/5/2026 - Zacks Investment Research
155,732 Shares in West Pharmaceutical Services, Inc. $WST Acquired by Border to Coast Pensions Partnership Ltd
2/5/2026 - MarketBeat
West Pharmaceutical Services (WST) Projected to Post Earnings on Thursday
2/5/2026 - MarketBeat
West Pharmaceutical Services (WST, $237.05) RSI Indicator left the oversold zone on February 04, 2026
2/5/2026 - Tickeron - Stocks
West Pharmaceutical Services (WST, $230.95) RSI Indicator left the oversold zone on February 03, 2026
2/4/2026 - Tickeron - Stocks
Reasons to Add Cooper Companies Stock to Your Portfolio Now
2/3/2026 - Zacks Investment Research
Truist Financial Corp Has $7.64 Million Position in West Pharmaceutical Services, Inc. $WST
2/3/2026 - MarketBeat
West Pharmaceutical Services (WST, $237.5) RSI Indicator left the oversold zone on February 02, 2026
2/3/2026 - Tickeron - Stocks
Analysts' Opinions Are Mixed on These Healthcare Stocks: Eli Lilly & Co (LLY), West Pharmaceutical Services (WST) and Humana (HUM)
2/1/2026 - TipRanks Financial Blog
New York State Common Retirement Fund Has $23.06 Million Position in West Pharmaceutical Services, Inc. $WST
2/1/2026 - MarketBeat
Assessing West Pharmaceutical Services (WST) After A 32% One-Year Share Price Pullback
2/1/2026 - Simply Wall St
Here's Why West Pharmaceutical (WST) Is a Great 'Buy the Bottom' Stock Now
1/30/2026 - Zacks Investment Research
3 Cash-Producing Stocks with Open Questions
1/30/2026 - StockStory Articles
Is West Pharmaceutical (WST) Refocusing on Larger-Volume SmartDose a Quiet Shift in Its Strategic Moat?
1/29/2026 - Simply Wall St
ActivePassive U.S. Equity ETF Buys 220 Shares of West Pharmaceutical Services Inc (WST)
1/29/2026 - GuruFocus
Income Statement
Total Revenue (TTM)
$3.02B
EBITDA (TTM)
$801.40M
EBIT (TTM)
$636.30M
Net Income (TTM)
$491.70M
Balance Sheet
Total Assets (Q)
$4.11B
Total Debt (Q)
$303.00M
Total Liabilities (Q)
$1.05B
Book Value Per Share (Q)
$42.44
Cash Flow
Cash from Operations (TTM)
$693.80M
Cash from Investing (TTM)
-$314.60M
Cash from Financing (TTM)
-$242.30M
Net Change in Cash (TTM)
$137.60M
Filings
Filing Date
Thursday, October 23, 2025
Period Date
Tuesday, September 30, 2025
Next Filing
Week of Feb 16 and 20 (est)
Price History
Loading...
Beta
0.78
7-Day Total Return
8.05%
30-Day Total Return
-8.97%
60-Day Total Return
-8.82%
90-Day Total Return
-8.00%
Year to Date Total Return
-9.66%
1-Year Total Return
-23.02%
2-Year Total Return
-38.79%
3-Year Total Return
-7.96%
5-Year Total Return
-14.74%
52-week Low
Apr 09, 2025 - $187.43
52-week High
Feb 11, 2025 - $325.20
Valuation
Market Cap
$17.91B - Large Cap
Enterprise Value
$17.58B
Price/Sales (TTM)
5.99
Price/Book (Q)
5.87
Dividends and Shares
Shares Outstanding
72.60M
Dividend Per Share (Most Recent)
$0.22
Dividend Per Share (TTM)
$1.07
Corporate Info
Website
www.westpharma.com
Phone Number
610 594 2900
Address
530 Herman O. West Drive
Exton, PA 19341-1147
Country
United States
Year Founded
1923
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa... more
NYSE 02/10/2026 12:23PM Eastern Quotes delayed